18.19
前日終値:
$18.21
開ける:
$18
24時間の取引高:
419.77K
Relative Volume:
0.12
時価総額:
$4.98B
収益:
$426.45M
当期純損益:
$197.67M
株価収益率:
22.18
EPS:
0.82
ネットキャッシュフロー:
$110.10M
1週間 パフォーマンス:
+1.74%
1か月 パフォーマンス:
-8.47%
6か月 パフォーマンス:
+5.89%
1年 パフォーマンス:
+57.23%
Adma Biologics Inc Stock (ADMA) Company Profile
ADMA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ADMA
Adma Biologics Inc
|
18.18 | 4.98B | 426.45M | 197.67M | 110.10M | 0.82 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
446.28 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
523.47 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
323.18 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
561.17 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
240.30 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-07-19 | 再開されました | Raymond James | Strong Buy |
2022-10-13 | 開始されました | Mizuho | Buy |
2021-11-11 | アップグレード | Raymond James | Outperform → Strong Buy |
2021-11-09 | 開始されました | Cantor Fitzgerald | Overweight |
2019-06-04 | 開始されました | Jefferies | Buy |
2019-04-15 | 繰り返されました | H.C. Wainwright | Buy |
2019-02-07 | 再開されました | H.C. Wainwright | Buy |
2017-12-11 | 繰り返されました | Maxim Group | Buy |
2017-11-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
2017-01-23 | アップグレード | Maxim Group | Hold → Buy |
2016-08-01 | ダウングレード | Maxim Group | Buy → Hold |
2016-07-25 | 繰り返されました | Maxim Group | Buy |
2015-05-13 | 繰り返されました | Maxim Group | Buy |
2014-12-08 | 開始されました | Oppenheimer | Outperform |
2014-12-01 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Adma Biologics Inc (ADMA) 最新ニュース
(ADMA) On The My Stocks Page - news.stocktradersdaily.com
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales? - sharewise
ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade) - Seeking Alpha
ADMA Biologics Stock Soars Amid Biotech Growth Nasdaq Composite Gains - Kalkine Media
The 8.3% return this week takes ADMA Biologics' (NASDAQ:ADMA) shareholders three-year gains to 964% - simplywall.st
ADMA Biologics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – ADMA - ACCESS Newswire
Adma Biologics director sells $213,100 in stock - Investing.com Australia
Adma Biologics director sells $213,100 in stock By Investing.com - Investing.com South Africa
ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold? - Nasdaq
When (ADMA) Moves Investors should Listen - news.stocktradersdaily.com
adma biologics holds annual meeting, elects directors and approves proposals - Investing.com Australia
adma biologics holds annual meeting, elects directors and approves proposals By Investing.com - Investing.com South Africa
ADMA Biologics Holds Annual Stockholders Meeting - TipRanks
ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy? - sharewise
ADMA Biologics Vs. Grifols: Which Plasma Therapy Stock Is The Better Buy? - Barchart.com
Where are the Opportunities in (ADMA) - news.stocktradersdaily.com
Cetera Investment Advisers Decreases Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Adma Biologics director sells $182,635 in common stock - Investing.com Australia
Adma Biologics director sells $182,635 in common stock By Investing.com - Investing.com South Africa
Bank of America Corp DE Has $13.14 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Exploring High Growth Tech Stocks In The US May 2025 - Yahoo
Are Options Traders Betting on a Big Move in ADMA Biologics Stock? - The Globe and Mail
Are Options Traders Betting On A Big Move In ADMA Biologics Stock? - Barchart.com
BNP Paribas Financial Markets Sells 674,016 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Ameriprise Financial Inc. Acquires 88,542 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
These 5 Buy-Ranked Mid-Cap Stocks Are Flying High Year to Date - The Globe and Mail
(ADMA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
FY2025 EPS Estimates for ADMA Biologics Decreased by Analyst - Defense World
Amid Bumpy Biotech Trade, I'm Eyeing These Two Stocks - TheStreet Pro
Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus
ADMA Biologics (NASDAQ:ADMA) Rating Lowered to “Sell” at StockNews.com - Defense World
PBYI Stock Rises as Q1 Earnings and Sales Beat Estimates - The Globe and Mail
Revenue Gains, Bold Guidance Lift ADMA Shares - FXEmpire
Adma Biologics (ADMA) Misses Q1 Earnings and Revenue Estimates - MSN
ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss (NASDAQ:ADMA) - Seeking Alpha
ADMA Biologics Reports Strong Growth and Strategic Advances - TipRanks
ADMA Biologics (ADMA) Receives Price Target Upgrade from Raymond - GuruFocus
ADMA Biologics (ADMA) Receives Price Target Upgrade from Raymond James | ADMA Stock News - GuruFocus
ADMA's Q1 Earnings and Revenues Miss: Buy, Sell or Hold the Stock? - Yahoo Finance
Why IBD 50's No. 2 Stock, ADMA Biologics, Just Plummeted By Double Digits - MSN
Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings - Benzinga
Adma Biologics price target raised to $32 from $25 at Raymond James - TipRanks
Raymond James Increases Price Target for ADMA Biologics | ADMA Stock News - GuruFocus
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2025 Earnings Call Transcript - Insider Monkey
ADMA Biologics Inc (ADMA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
ADMA Biologics Inc (ADMA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Initiatives Propel Future Outlook - GuruFocus
Adma Biologics: Q1 Earnings Snapshot - New Haven Register
ADMA Biologics Reports Strong Q1 2025 Financial Growth - TipRanks
ADMA Biologics Inc earnings missed by $0.01, revenue topped estimates - Investing.com Nigeria
Adma Biologics Inc (ADMA) 財務データ
収益
当期純利益
現金流量
EPS
Adma Biologics Inc (ADMA) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Grossman Adam S | President and CEO |
Jun 16 '25 |
Sale |
20.81 |
21,000 |
437,010 |
2,043,850 |
ELMS STEVE | Director |
Jun 13 '25 |
Option Exercise |
3.43 |
332,680 |
1,140,763 |
420,010 |
ELMS STEVE | Director |
Jun 16 '25 |
Sale |
20.24 |
194,749 |
3,941,720 |
87,330 |
ELMS STEVE | Director |
Jun 13 '25 |
Sale |
20.82 |
137,931 |
2,871,723 |
282,079 |
ELMS STEVE | Director |
Jun 12 '25 |
Sale |
21.69 |
92,941 |
2,015,890 |
2,031,730 |
大文字化:
|
ボリューム (24 時間):